IQVIA Holdings Inc
NYSE:IQV

  • LAST PRICE
    235.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    94.0000/ 2
  • Ask / Lots
    269.9000/ 1
  • Open / Previous Close
    0.0000 / 235.0000
  • Day Range
    ---
  • 52 Week Range
    167.4200
    261.7300
  • Volume
    ---

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
IQV
IQVIA Holdings Inc
42.8B
32.1x
+46.62%
BIIB
Biogen Inc
33.5B
28.7x
-18.14%
MRNA
Moderna Inc
50.8B
-8.5x
---
ICLR
ICON PLC
26.1B
38.3x
+4.68%
REGN
Regeneron Pharmaceuticals Inc
106.7B
28.6x
+10.93%
GRFS
Grifols SA
6.6B
78.3x
---
As of 2024-05-17

Company Information

IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The Company's Connected Intelligence delivers insights enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients. The Company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides mission critical information, technology solutions and real-world insights and services to life science clients. Research & Development Solutions primarily serves biopharmaceutical clients, provides outsourced clinical research and clinical trial services. Contract Sales & Medical Solutions provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market.

Contact Information

Headquarters
2400 ELLIS ROADDURHAM, NC, United States 27703
Phone
919-998-2000
Fax
302-636-5454

Executives

Chairman of the Board, Chief Executive Officer
Ari Bousbib
Interim Chief Financial Officer, Executive Vice President
Ronald Bruehlman
President - Corporate Strategy and Enterprise Networks
Kevin Knightly
President - Research and Development Solutions
Walter Staub
Executive Vice President, General Counsel, Secretary
Eric Sherbet

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$42.8B
Revenue (TTM)
$15.1B
Shares Outstanding
182.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.55
EPS
$7.33
Book Value
$33.67
P/E Ratio
32.1x
Price/Sales (TTM)
2.8
Price/Cash Flow (TTM)
17.2x
Operating Margin
13.31%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.